Business Context and Reporting Period
This Form 8-K Current Report was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on November 2, 2021, covering events occurring on October 29, 2021. The registrant is a Delaware corporation headquartered in Menlo Park, California, and is classified as an emerging growth company. The report details the appointment of a new executive officer and the terms of their employment agreement.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on executive compensation and corporate governance.
Material Changes
The primary material change reported is the appointment of Quan Anh Vu as Chief Operating Officer/Chief Business Officer (COO/CBO), effective October 29, 2021. Mr. Vu brings extensive experience in life sciences executive management, including prior roles as CEO of Baleena Bioscience, Inc. and Managing Director at Solganick & Co.
Guidance, Outlook, and Management Commentary
The filing outlines the specific terms of the Executive Employment Agreement entered into on October 27, 2021, effective November 1, 2021:
- Base Salary: $390,000 per year, subject to annual increases of up to 5%. Salary increases by $10,000 upon completion of a financing of $50 million or more.
- Annual Bonus: Target opportunity of 50% of base salary, payable in cash, stock, or a combination, based on performance objectives.
- Equity Grant: Options to purchase 275,000 shares of common stock with a 10-year term. Vesting occurs over 48 equal monthly installments, with acceleration provisions for death, disability, termination without cause, good reason, or change of control.
- Term: Initial term of three years, renewable for additional one-year terms.
- Severance: In the event of termination without cause or resignation for good reason, the executive is entitled to 12 months of base salary (pro-rated in the first year), accrued bonuses, and health insurance payments.
The filing does not provide specific financial guidance, risk factors, or contingencies beyond the standard terms of the employment contract.
Investor Verification Checklist
- Verify the exact exercise price of the 275,000 stock options, as the filing states it will be determined after the Form 10-Q filing.
- Confirm the company's current cash position and ability to fund the $390,000 annual salary and potential bonus obligations.
- Review the full text of the Employment Agreement (Exhibit 10.1) for detailed definitions of "Cause" and "Good Reason."
- Monitor future filings for the $50 million financing milestone that triggers a salary increase.